Category: Biosimilars
Japan Biosimilars
-
Japan Biosimilars Market, By Product (Monoclonal Antibodies, Recombinant Hormones, Immunomodulators, Anti-inflammatory Agents, Other), By Application (Blood Disorders, Growth Hormonal Deficiency, Chronic and Autoimmune Disorders, Oncology, Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition Forecast & Opportunities, 2020-2030F
... By Region, Competition Forecast & Opportunities, 2020-2030F Japan Biosimilars Market was valued at USD 502.09 Million in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 10.12% through ... Read More
-
Japan Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Diabetology, Respiratory, Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, FY2018-FY2032F
... By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, FY2018-FY2032F Japan generic drugs market is projected to witness a CAGR of 7.81% during the forecast period FY2024-FY2032, growing from USD ... Read More
-
Japan Human Insulin Market By Product Type (Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin, Biosimilars), By Application (Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus), By Type (Human Insulin, Insulin Analog), By Distribution Channel (Hospitals, Retail Pharmacies, and Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
... Pharmacies, and Others), By Region, Competition, Forecast & Opportunities, 2020-2030F Japan Human Insulin Market was valued at USD 840.23 Million in 2024 and is expected to reach USD 1206.28 Million by 2030 with a CAGR ... Read More
-
2024 Japan Biosimilars Forecast (2025-2030 Outlook)-Market Opportunities Report
... market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published historically ... Read More
-
Asia Pacific Next Generation Antibody Market, By Therapeutic Area (Oncology, Autoimmune/Inflammatory); By Technology (Antibody-Drug Conjugates (ADC's), Bispecific Antibodies, FC Engineered Antibodies, Antibody Fragments and Antibody-like Proteins, Biosimilar Antibody Products); By Country (China, India, Japan, South Korea, Indonesia, Vietnam, Malaysia, Rest of Asia Pacific), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... antibody research and development programs, advancements in biotechnology, and expanding healthcare infrastructure. BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Asia Pacific Next Generation Antibody Market size ... Read More
-
Japan Biosimilars: Landscape Today, Outlook Tomorrow
... of biosimilar tool to curb healthcare cost Biosimilars uptake varies as per each opportunity, Remicade BS vs. Rituxan BS Two poles of the curve A few skipping NHI listing due to manufacturing issues associated with ... Read More
Research Assistance
